LINSITINIB MECHANISM OF ACTION FOR DUMMIES

Linsitinib is a small-molecule inhibitor of IGF-1R, taken 2 times everyday. Within the section 2b/3 LIDS trial, far more patients dealt with having a 150mg dose with the drug accomplished a 2mm or superior reduction in proptosis right after 24 months when compared to placebo, which was a statistically substantial variance.Hepatic transaminases had